Back to Search
Start Over
THE DME PIPELINE: WHAT'S NEXT?
- Source :
-
Review of Ophthalmology . Mar2022, Vol. 29 Issue 3, p56-73. 6p. - Publication Year :
- 2022
-
Abstract
- The article presents the pipeline for diabetic macular edema treatments has expanded in recent years, with several promising products in various phases of clinical trials. Topics include the big news in DME treatment, however, is the FDA approval of Roche's Vabysmo in late January, and Vabysmo targets and inhibits two disease pathways linked to a number of vision-threatening retinal conditions by neutralizing angiopoietin-2 (Ang-2) and vascular endothelial growth factor-A.
- Subjects :
- *LASIK
*CLINICAL trials
Subjects
Details
- Language :
- English
- ISSN :
- 10810226
- Volume :
- 29
- Issue :
- 3
- Database :
- Academic Search Index
- Journal :
- Review of Ophthalmology
- Publication Type :
- Periodical
- Accession number :
- 155715643